COVID-19
Regístrese
metricas
covid
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Mortality and sequelae of tuberculous meningitis in a high-resource setting: A c...
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Original article
Mortality and sequelae of tuberculous meningitis in a high-resource setting: A cohort study, 1990–2017
Mortalidad y secuelas de la meningitis tuberculosa en Barcelona (España): Estudio de cohortes, 1990-2017
Lluïsa Guillema,
Corresponding author
lui.gui.ti@gmail.com
lguillem@bellvitgehospital.cat

Corresponding authors.
, Juan Espinosab, Júlia Laporte-Amargosa, Adrián Sánchez-Montalvác,d, María D. Grijotae,f, Miguel Santine,g,
Corresponding author
msantin@bellvitgehospital.cat
msantin.bcn@gmail.com

Corresponding authors.
a Department of Infectious Diseases, Bellvitge University Hospital-Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
b Department of Infectious Diseases, Vall d’Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain
c Department of Infectious Diseases, Vall d’Hebron University Hospital, Programa de Salut Internacional de l’Institut Català de la Salut (PROSICS), Barcelona, Spain
d Mycobacterial Diseases Study Group (Grupo de estudio de Infecciones por Micobacterias, Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica, GEIM-SEIMC) Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Spain
e Tuberculosis Unit, Department of Infectious Diseases, Bellvitge University Hospital-Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
f Department of Fundamental and Medical-Surgical Nursing, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
g Department of Clinical Sciences, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
Read
250
Times
was read the article
84
Total PDF
166
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2022.10.008
The statistics are updated each day
Year/Month Html Pdf Total
2024 September 28 10 38
2024 August 8 2 10
2024 July 1 0 1
2024 May 5 1 6
2024 April 9 1 10
2024 March 115 46 161
2023 March 0 2 2
2023 January 0 2 2
2022 December 0 20 20

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica
Free access articles
Uncommon lip lesions in an HIV...
10.1016/j.eimc.2024.06.017
Tolerance of Atovacuona/proguanil in off-label...
10.1016/j.eimc.2024.06.012


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos